Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	71.23	33.99	19.85
Graham Fair Price	-26.63	19.10	26.04
PEG	201.38	-0.35	0.12
Price/Book	-2.40	5.22	5.35
Price/Cash Flow	24457.33	4025.10	16.39
Prices/Earnings	84.23	16.36	8.88
Price/Sales	63.11	1.82	1.12
Price/FCF	24457.33	4025.10	16.39
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	13.53	0.23	0.20
Operating Margin	-25.84	0.04	0.05
ROA	-45.74	0.02	0.03
ROE	0.15	0.08	-47.02
ROIC	0.12	0.05	-57.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.01	-95.69
Dividends QOQ	< 0.005	0.02	200.28
EBIT QOQ	1.06	-0.55	-48.02
EPS QOQ	0.76	-0.46	-38.87
FCF QOQ	10.23	-1.00	-90.27
Revenue QOQ	0.50	-0.40	-21.01
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	38.32	69.27	80.76
Days Sales Outstanding (DSO)	5.77	7.83	35.75
Inventory Turnover	2.35	1.30	-44.68
Debt/Capitalization	0.37	0.36	-0.60
Quick Ratio	0.30	0.32	7.52
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	14.14	14.26	0.81
Cash	6.70	7.91	18.08
Capex	-0.85	-0.70	17.06
Free Cash Flow	4.62	0.02	-99.60
Revenue	67.84	40.92	-39.68
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.00	1.01	1.51
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.67	4.50	68.82
Naive Interpretation	Member

06 - Financial Health · Bad

Rating